Christine M Lin1, Ronald G Gill. 1. aDivision of Pulmonary Sciences and Critical Care Medicine, Department of Medicine bDepartment of Surgery and Immunology, University of Colorado Denver, Denver, Colorado, USA.
Abstract
PURPOSE OF REVIEW: The T cell-dependent recognition of allogeneic tissues and organs is complicated by the fact that both donor and host antigen-presenting cells can present donor antigens to host T cells. As such, these pathways result in T cells that can be restricted to either donor ('direct') or host ('indirect') major histocompatibility complex (MHC). These pathways are well recognized, but how these distinct patterns actually dictate allograft recognition is less clear. Thus, the purpose of the review is to summarize results from preclinical animal models in an attempt to clarify the distinct forms of allograft rejection dictated by these recognition pathways. RECENT FINDINGS: CD4 and CD8 donor MHC-restricted T cells are sufficient to reject allografts by a T-cell receptor-mediated direct ('cognate') interaction using a defined array of effector molecules. Conversely, 'noncognate' host MHC-restricted CD4 T cells must interact with intermediate host-type antigen-presenting cells and so greatly amplify the response by triggering antibody and inflammatory responses. SUMMARY: Importantly, 'cognate' CD4 and CD8 T cells have strikingly similar requirements for rejection, suggesting that this effector mechanism is dictated by the nature of allograft recognition rather than by T-cell subset. Conversely, 'noncognate' allograft recognition drives an increasingly appreciated role for inciting innate immunity in mediating allograft injury.
PURPOSE OF REVIEW: The T cell-dependent recognition of allogeneic tissues and organs is complicated by the fact that both donor and host antigen-presenting cells can present donor antigens to host T cells. As such, these pathways result in T cells that can be restricted to either donor ('direct') or host ('indirect') major histocompatibility complex (MHC). These pathways are well recognized, but how these distinct patterns actually dictate allograft recognition is less clear. Thus, the purpose of the review is to summarize results from preclinical animal models in an attempt to clarify the distinct forms of allograft rejection dictated by these recognition pathways. RECENT FINDINGS:CD4 and CD8donor MHC-restricted T cells are sufficient to reject allografts by a T-cell receptor-mediated direct ('cognate') interaction using a defined array of effector molecules. Conversely, 'noncognate' host MHC-restricted CD4 T cells must interact with intermediate host-type antigen-presenting cells and so greatly amplify the response by triggering antibody and inflammatory responses. SUMMARY: Importantly, 'cognate' CD4 and CD8 T cells have strikingly similar requirements for rejection, suggesting that this effector mechanism is dictated by the nature of allograft recognition rather than by T-cell subset. Conversely, 'noncognate' allograft recognition drives an increasingly appreciated role for inciting innate immunity in mediating allograft injury.
Authors: T Hirohashi; C M Chase; P Della Pelle; D Sebastian; A Alessandrini; J C Madsen; P S Russell; R B Colvin Journal: Am J Transplant Date: 2011-11-09 Impact factor: 8.086
Authors: Martin H Oberbarnscheidt; Qiang Zeng; Qi Li; Hehua Dai; Amanda L Williams; Warren D Shlomchik; David M Rothstein; Fadi G Lakkis Journal: J Clin Invest Date: 2014-07-01 Impact factor: 14.808
Authors: Kym R Garrod; Feng-Chun Liu; Luette E Forrest; Ian Parker; Sang-Mo Kang; Michael D Cahalan Journal: J Immunol Date: 2010-02-05 Impact factor: 5.422
Authors: Todd J Grazia; Robert J Plenter; Sarah M Weber; Helen M Lepper; Francisco Victorino; Martin R Zamora; Biagio A Pietra; Ronald G Gill Journal: Transplantation Date: 2010-01-15 Impact factor: 4.939
Authors: Adam L Burrack; Laurie G Landry; Janet Siebert; Marilyne Coulombe; Ronald G Gill; Maki Nakayama Journal: J Immunol Date: 2018-01-08 Impact factor: 5.422
Authors: Natalia F Smirnova; Thomas M Conlon; Carmela Morrone; Peter Dorfmuller; Marc Humbert; Georgios T Stathopoulos; Stephan Umkehrer; Franz Pfeiffer; Ali Ö Yildirim; Oliver Eickelberg Journal: JCI Insight Date: 2019-02-07